BNTC

Benitec Biopharma Inc.

Insider Trades

NameValueActionPriceCurrent Price
Suvretta Capital Management, LLCDirector, 10 Percent Owner:
$884k65.8k shares
BuyDec 29, 2025
$13.44
--
Suvretta Capital Management, LLCDirector, 10 Percent Owner:
$156k11.6k shares
BuyDec 29, 2025
$13.44
--
Suvretta Capital Management, LLCDirector, 10 Percent Owner:
$188k14.3k shares
BuyDec 26, 2025
$13.10
--
Suvretta Capital Management, LLCDirector, 10 Percent Owner:
$33k2.5k shares
BuyDec 26, 2025
$13.10
--
Suvretta Capital Management, LLCDirector, 10 Percent Owner:
$547k42.6k shares
BuyDec 23, 2025
$12.85
--
Suvretta Capital Management, LLCDirector, 10 Percent Owner:
$95k7.4k shares
BuyDec 23, 2025
$12.85
--

News

globenewswire.comBenitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Updateglobenewswire.comMay 14globenewswire.comBenitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meetingglobenewswire.comApr 28